Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • May 01, 2025, 00:25 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: PAVmed Inc. - Series Z Warrant.

Comment Full text

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • May 01, 2025, 00:25 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: PAVmed Inc. - Series Z Warrant.

Comment Full text

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • April 30, 2025, 22:44 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Delinquent.

Comment Full text

BioNexus Gene Lab Corp (BGLC)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Artelo Biosciences Inc. (ARTL)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ALX Oncology Inc (ALXO)

  • Technical Exchange News
  • April 30, 2025, 22:43 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Vor Biopharma Inc (VOR)

  • Technical Exchange News
  • April 30, 2025, 01:43 UTC
  • 44
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Quoin Pharmaceuticals Ltd DRC (QNRX)

  • Technical Exchange News
  • April 30, 2025, 01:42 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 134
  • 135
  • 136
  • 137
  • 138
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1536)
  • SEC News(176606)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118287)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin